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Background
Plasmodium falciparum cGMP-dependent protein kinase
(pfPKG) is a validated therapeutic target of malaria. As
a key regulator of its life cycle, pfPKG plays a crucial
role in both the sexual and asexual blood-stages that
cause malaria pathology. Inhibiting pfPKG blocks prolif-
eration and transmission of the parasite [1,2]. However
the development of pfPKG-specific inhibitor has been
greatly hampered by the lack of high-resolution struc-
ture information to guide drug design.
Targeting the ATP binding site of pfPKG is an approach
commonly associated with low specificity and toxicity [3].
Therefore, we aim to target a domain that is unique to
this kinase, the cyclic nucleotide binding (CNB) domain.
Since previous studies demonstrated the fourth-cyclic
nucleotide binding (CNB-D) domain of pfPKG to be the
most important for the kinase activation [4] we focused on
this domain to understand its role in cGMP dependent
activation.
Results
To understand the functional roles of the CNB-D domain
in pfPKG activation, we determined crystal structures of
CNB-D with and without cGMP at 1.9 and 2.0 Å, respec-
tively. The structure of the cGMP complex reveals that
CNB-D binds cGMP through [1] leucine and arginine
residues on the b5 strand and a threonine within the
phosphate binding cassette (PBC) that interact specifi-
cally with the guanine moiety through hydrogen bonding
[2] a conserved arginine residue within the PBC that pro-
vides a hydrophobic capping interaction with cGMP.
The structure also shows that the side chain of the con-
served arginine residue within the PBC interacts with
two conserved glutamine and aspartic acid residues on
the aC-helix forming a stable salt bridge. Mutation of the
salt bridge forming residues drastically reduces its affinity
for cGMP and increases activation constants (Ka) of the
full-length kinase. Furthermore, comparison with the apo
structure shows that the salt bridge stabilizes the cGMP
bound conformation and shields the cGMP binding
pocket from solvent by anchoring the highly dynamic
aC-helix.
Conclusion
Our structures and accompanying mutagenesis studies
demonstrate functional roles of the CNB-D domain in
cGMP binding and activation. Our crystal structures also
reveal the molecular details of cGMP pocket and the
unique salt bridge that can be differentially targeted for
the development of pfPKG-specific inhibitor.
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